Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Bioentrepreneur
  • Published:

University biotech patenting 2013

An Erratum to this article was published on 09 September 2014

This article has been updated

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Biotech patent trends, 2009–2013.

Change history

  • 10 July 2014

    In the version of this article initially published, the total number of patents assigned to Cornell in Table 1 was incorrect. The correct number for the 2009-2013 time period is 122. Also, total patents assigned to Penn State and Purdue were 45 apiece over the time period, bringing them in above Ohio State University and INSERM, which they replace in our ranking in Table 1. The errors have been corrected in the HTML and PDF versions of the article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kathryn Paisner.

Ethics declarations

Competing interests

K.P. is employed by IP Checkups Inc.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huggett, B., Paisner, K. University biotech patenting 2013. Nat Biotechnol 32, 512 (2014). https://doi.org/10.1038/nbt.2918

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt.2918

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research